Lyndra's ultralong-acting pill shows promise in schizophrenia phase 2

The study pitted Lyndra’s treatment, an ultralong-acting version of the antipsychotic risperidone, against immediate-release risperidone in 34 patients diagnosed with schizophrenia or schizoaffective disorder.

4 Likes

Jesus-fricking-christ, how many formulations of risperidone need to be made?!?!

4 Likes

Wow good to know!
I take risperidone.
Thanks @everhopeful

2 Likes

Probably just plain old risperidone with jacked up prices

2 Likes

Our current meds are good enough for positive symptoms. We need meds for negative and cognitive symptoms.

3 Likes